- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/02 - Drugs for disorders of the nervous system for peripheral neuropathies
Patent holdings for IPC class A61P 25/02
Total number of patents in this class: 1993
10-year publication summary
|
69
|
66
|
80
|
115
|
145
|
202
|
164
|
205
|
175
|
56
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2961 |
30 |
| Shionogi & Co., Ltd. | 914 |
23 |
| Daiichi Sankyo Company, Limited | 1829 |
20 |
| Banyu Pharmaceutical Co., Ltd. | 107 |
16 |
| Novartis AG | 11238 |
15 |
| The Regents of the University of California | 18943 |
14 |
| Mitsubishi Tanabe Pharma Corporation | 579 |
14 |
| Ono Pharmaceutical Co., Ltd. | 454 |
14 |
| Osaka University | 3143 |
14 |
| Bristol-myers Squibb Company | 5080 |
13 |
| Kyoto University | 2732 |
13 |
| Toray Industries, Inc. | 6652 |
12 |
| Grünenthal GmbH | 625 |
12 |
| Janssen Pharmaceutica N.V. | 3839 |
11 |
| Biogen MA Inc. | 926 |
11 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
11 |
| Nippon Zoki Pharmaceutical Co., Ltd. | 155 |
11 |
| Tenacia Biotechnology (Hong Kong) Co., Limited | 35 |
11 |
| Pfizer Inc. | 3322 |
10 |
| Kinki University | 225 |
10 |
| Other owners | 1708 |